Last reviewed · How we verify

Heart Failure drugs

Ege University · Phase 1 active Small molecule Quality 15/100

Heart Failure drugs is a Small molecule drug developed by Ege University. It is currently in Phase 1 development.

At a glance

Generic nameHeart Failure drugs
SponsorEge University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Heart Failure drugs

What is Heart Failure drugs?

Heart Failure drugs is a Small molecule drug developed by Ege University.

Who makes Heart Failure drugs?

Heart Failure drugs is developed by Ege University (see full Ege University pipeline at /company/ege-university).

What development phase is Heart Failure drugs in?

Heart Failure drugs is in Phase 1.

What are the side effects of Heart Failure drugs?

Common side effects of Heart Failure drugs include Hypotension, Renal impairment, Atrial fibrillation, Urinary tract infection, Hyperkalaemia, Dizziness.

Related